The susceptibility to develop seropositive rheumatoid arthritis (RA) has been linked to specific genomic polymorphisms within the HLA complex. Two different haplotypes have been associated with the disease, HLA-DR1 and HLA-DR4. To investigate the link between such phenotypic disease associations and potential immune mechanisms we used alloreactive and antigen-specific human T cell clones. Here we describe a panel of alloreactive T cell clones directed to polymorphic determinants encoded by the third hypervariable region (hvr) of the HLA-DR #,-chain. T cell determinants defined by these clones are shared among HLA-DR1, HLA-Dw4, HLA-Dw13, HLA-Dw14, and HLA-Dw15, and are frequent in a population of RA patients. To study the role of such disease-associated epitopes in antigen-restricted T cell recognition we generated T cell clones from RA patients specific for mycobacterial antigens, Epstein-Barr virus antigens, and tetanus toxoid. In all three antigenic systems T cell clones were restricted to either HLA-DR1 or HLA-DR4. These data suggest that the polymorphisms within the first and second hvr of the HLA-DR B,-chain that are distinct in HLA-DR1 and HLA-DR4 and not associated with the disease are crucially involved in the recognition of antigens. Polymorphic determinants encoded by the third hvr are shared among disease-associated haplotypes and may function to mediate the interaction of alloreactive T cell receptor molecules with the HLA complex. (J. Clin. Invest.
contribute to the disease. One major element is a genetic predisposition that has been linked to gene products ofthe human MHC locus, the HLA complex. Initially, cellular and serological typing techniques have documented an association of the disease with HLA-DR4 alleles (1) (2) (3) . More recently, molecular biology has helped to understand the allelic variation of the serologically defined broad specificity HLA-DR4. Genetic subtypes of HLA-DR4 have been described and have been attributed to the polymorphism of at least five distinct DRB molecules that combine on the cell surface with a nonpolymorphic DRa-chain (4, 5) .
The information on the genetic organization of HLA class II loci might help us to understand the molecular basis of the genetic susceptibility to seropositive RA. Many studies have suggested that the disease is associated with the Dw4, Dw14, and Dw 15 subtypes of the HLA-DR4 family, but not with the Dw10 subtype (1, (6) (7) (8) (9) (10) . We have recently used alloreactive human T cell clones to study HLA-DR molecules expressed on the cells of RA patients and have shown that HLA-Dw14-reactive T cell clones can identify shared T cell recognition sites in patients who do not carry the classical disease-associated haplotype HLA-DR4 (8, 1 1) . We have mapped these T cell epitopes and have correlated the conformational determinants to sequence homologies within the third hypervariable region (hvr) of the DRB,-chain ( 12) . These findings opened the possibility that the genetic predisposition was linked to one or more T cell epitopes encoded by HLA-DR genes (13, 14) . Such disease-associated T cell epitopes could then be recognized by T lymphocytes in the context of more than one HLA-haplotype explaining the incomplete association of the disease with one specific allele. Such a model would be in support of previous reports describing an association of RA with the HLA-DR1 haplotype that have recently been confirmed by using specific oligonucleotide probes to identify susceptibility alleles (15) (16) (17) (18) .
The role of disease-associated HLA-molecules in the pathogenesis of seropositive RA is not understood. As one hypothesis we have suggested that the disease-associated molecules might function to select, bind, and present an arthritogenic antigenic fragment to T lymphocytes, thus initiating a chronic destructive inflammatory response in the synovia (8) .
The purpose of this study was to identify HLA-encoded T cell recognition sites that are highly frequent in RA patients and investigate the biological function of such determinants in the recognition of antigens. Here we show that alloreactive T cell clones can be used to recognize a cluster of T cell epitopes associated with RA. These T cell epitopes are encoded by the third hvr of the HLA-DRJ,,-chain and are shared among the two disease-associated HLA haplotypes DR4 and DR1. Studies with antigen-specific T cell clones demonstrated that the function of these epitopes was clearly distinct in allorecognition and HLA-restricted recognition of antigens, suggesting that their biological function in the pathogenesis of RA might be linked to their interaction with T cell receptor molecules and not to their selective binding of an arthritogenic antigen.
Methods
Patients. Patients who fulfilled the American Rheumatism Association 1987 revised criteria for RA were selected for analysis (19) . All patients were positive for rheumatoid factor. Patients with longstanding and severe progressive disease were included in the first study group (patients RA 1-RA 15) . MHC class II antigens were analyzed by conventional HLA-DR and HLA-DQ typing. A second group of patients with seropositive RA (RA16-RA39) was randomly selected from patients treated at the outpatient clinic.
Additionally, a distinct subset of 11 patients with seronegative polyarthritis were studied. In these patients the disease started after age 60 and presented with systemic symptoms reminiscent of polymyalgia rheumatica (20 
Results
T cell recognition sites encoded by the HLA-DR 13,-chain associated with seropositive RA. We have recently described a panel of alloreactive human T cell clones that are specific for a cluster of T cell epitopes expressed by HLA-DR4' stimulator cells (12) . Panel studies on homozygous typing cells representing the different subtypes of HLA-DR4 demonstrated that these T cell clones recognized structures crucially determined by the third hvr of the HLA-DR 013-chain. A subset of HLA-DR4-specific alloreactive T cell clones crossreacted with HLA-DR encoded molecules on HLA-DR1+ stimulators.
Since the HLA-DR f,-chain of the HLA-DRl and HLA-DR4 alleles are distinct for the first and second hvr but very similar for the third hvr, these findings suggest that a cluster of T cell recognition sites is shared among HLA-DR 1 + and HLA-DR4' individuals.
We wanted to study whether these T cell epitopes were found on cells of patients with seropositive RA, a disease associated with HLA-DR1 and HLA-DR4. A group of patients with classical seropositive RA and severe disease was selected.
Cells of these patients were used to stimulate the proliferation of a panel of clones shown in Fig. 1 . All clones were previously characterized and found to be specific for a determinant shared by HLA-DR 1 and one or more subtypes of HLA-DR4 (Table I) ( 12) . As shown in Fig. 1 Fine specificity patterns of proliferative alloreactive T cell clones were determined in target inhibition studies with HLA-DR-, HLA-DQ-, and HLA-DP-specific MAb and in panel studies using defined lymphoblastoid cell lines as stimulator cells as previously described. structure recognized by the T cell clones is highly conserved in patients with severe seropositive RA.
To support the finding that alloreactive T cell recognition sites shared by HLA-DR1 and HLA-DR4 are highly frequent in patients with seropositive RA, we prospectively studied a second group of patients who fulfilled the diagnostic criteria for RA but were not selected for disease severity. Results ofRA patients and control patients are shown in Table II . Control patients were seen at our rheumatology clinic and were diagnosed to have seronegative RA of late onset. Both patients' groups were studied for the expression of HLA-DR4-and HLA-DR 1-encoded determinants with alloreactive T cell clones. The specificities of the two T cell clones El-10 and G 1-2 have been previously reported and are summarized in Table I (12) . T cell clones HKBl-l 1 and HKBl-15 were generated against an HLA-DR4 Dw4/HLA-DR 1 heterozygous patient with RA. Proliferation of both clones could be blocked by HLA-DR-specific MAb, but not by DQ-or DP-specific MAb. In panel studies HKBl-11 recognized a determinant shared by HLA-DR1+ and HLA-DR4 Dw4+ stimulators, whereas HKB 1-15 was predominantly specific for HLA-DR4 Dw4 with only a slight crossreaction on HLA-DR I stimulators (data not shown, Table I ). Again we found that T cell recognition sites defined by these alloreactive T cell clones were highly frequent in patients with seropositive RA (Table II) . Only 4 of the 24 patients with seropositive RA were negative for all four clones. Compared with the selected patient group with severe disease (Fig. 1) Antigen-specific recognition in patients with RA: crossreactivity between HLA-DRI and HLA-DR4 in allorecognition does not predict crossreactivity of antigen-specific T cells. To approach the question ofwhether the shared T cell recognition sites encoded by the third hvr are used as restriction elements to recognize antigen, we studied antigen-specific proliferation T cell recognition sites used by antigen-specific T cell clones of RA patients. To evaluate whether antigen-specific T cell clones restricted to the T cell recognition sites defined by the crossreactive alloreactive T cell clones are present in the repertoire of patients with seropositive RA, we established antigenspecific T cell clones directed to three different antigens: mycobacterial, EBV, and TT antigens. Antigen-reactive T cell clones were generated from RA patients with the following haplotypes: KE-HLA-DRl/l Dwl; SA-HLA-DR4/w6 Dw14; DO-HLA-DRl/4 Dwl4; KL-HLA-DRI/4 Dw4; and JE-HLA-DR4/5 Dw4. T cell clones whose proliferative responses could be blocked by the addition of HLA-DR-specific MAb were selected. To define the fine specificities DR-restricted T cell clones were stimulated with homozygous typing lines representing the HLA-DR haplotypes HLA-DRI through HLADRw IO preincubated with the appropriate antigen. Reactivity patterns of representative clones specific for the three tested antigens EBV, Myobacterium tuberculosis soluble extract, and TT are shown in Fig. 2 , a-c. T cell clones restricted to HLA-DRI were strictly specific for the antigen when presented by HLA-DR 1 + stimulator cells. None ofthese clones could recognize the antigen when it was presented by HLA-DR4' cells. Vice versa, antigen-reactive T cell clones restricted to HLA-DR4 only proliferated when stimulated with antigen-pulsed stimulator cells of the HLA-DR4 haplotype. They did not recognize the antigen in conjunction with HLA-DRl molecules. Some of the clones were specific for only one subtype within the HLA-DR4 family (JEE 1-1, SAP2-1, DOT2-1). The majority of antigen-specific T cell clones used restriction elements shared by different subtypes of the HLA-DR4 family.
Frequency of allogenic and antigen-specific T cell clones reactive to shared and allele-specific recognition sites expressed by HLA-DRI and HLA-DR4 molecules. In multiple cloning experiments we found a high frequency of alloreactive T cell clones that were specific for determinants shared among HLA-DR1 and HLA-DR4 molecules, while we were unable to establish antigen-restricted T cell clones reactive to HLA-DR I + and HLA-DR4+ antigen-pulsed stimulators. To support this observation we studied alloreactive and antigen-reactive T cell clones in parallel cloning experiments using cells of an RA patient to stimulate PBL from a normal donor and as responder cells to generate antigen-specific T cell clones.
The results of a representative experiment are shown in Table III T cell clones were raised in parallel from an HLA-Dw4-specific and an HLA-Dw4-restricted EBV-specific T cell line, respectively. PBL of the same patient with RA were used as responder cells to initiate the antigen-specific line and as stimulator cells for the alloreactive line. Growing T cell clones were characterized in target inhibition studies and in panel studies as described in Table I . Crossreactive patterns were confirmed after subcloning.
MAb to monomorphic determinants on HLA-DR molecules, indicating that they were directed against non-HLA-DR (Fig. 1) (8, 1 1) . Panel studies on stimulator cells exhibiting a limited sequence polymorphism have allowed us to map these T cell epitopes more precisely (12) . These studies have shown that the alloreactive T cell clones are reactive to structures that are determined by the third hvr of the HLA-DR #,(-chain. Provided that the three-dimensional structure of HLA class I molecules can be applied to HLA class II molecules, we predict that these T cell epitopes are located on an alpha-helical structure that forms the wall of the antigen binding groove and may have direct contact to the T cell receptor and/or the bound antigenic fragment ( 12) .
The T cell recognition sites that are seen by alloreactive T cell clones represent the molecular basis of the gene sequences associated with the disease. The strength of the association seems to be correlated to the severity of the disease. These findings are in accordance with earlier reports that severe seropositive RA has a strong association to HLA-DR4 and that patients with a severe variant of the disease, Felty's syndrome, are almost all HLA-DR4' (28) .
Having (30) (31) (32) (33) . In none of these systems were we able to establish a T cell clone that recognized antigen in restriction to both HLA-DR 1 + and HLA-DR4+ antigen-presenting cells (Fig. 2) . These findings suggest that the high frequency of crossreactive alloreactive T cell clones is unlikely to be explained by widely spread antigen fragments bound in the groove of the HLA-DR 1 and HLA-DR4 molecules (Table III) (35) . Support for this mechanism comes from a recent report describing a sequence homology between a hexapeptide of the EBV-encoded gpl 10 and the third hvr ofdisease-associated haplotypes (36) . Alternatively, the pathogenic role of disease-associated T cell epitopes might be to directly interact with T cell receptor molecules and thus shape the T cell repertoire (37) .
